James Brodack

James Brodack has a diverse work experience in the field of regulatory affairs and quality assurance. James started their career in 1983 as a Research Instructor in Radiology at Washington University School of Medicine. James then worked at Mallinckrodt Inc. as a Senior Research Chemist from 1990 to 2001. Subsequently, they joined Tyco Healthcare (formerly Mallinckrodt Inc.) as a Senior Regulatory Affairs Associate for a brief period. James then moved to Covidien (formerly Tyco Healthcare) as a Manager of Regulatory Affairs from 2001 to 2007. At Mallinckrodt Pharmaceuticals, they served as the Director of Regulatory Affairs from 2007 to 2015, where they had oversight of regulatory submissions for imaging drugs and medical devices. James then joined Guerbet as the Director of Regulatory Affairs in 2015 before moving to NorthStar Medical Radioisotopes, LLC. At NorthStar, they served as the Vice President of Regulatory Affairs/Quality Assurance from 2016 to 2018, and subsequently, as the Senior Vice President and Chief Regulatory Officer.

James Brodack attended Eastern Illinois University from 1975 to 1979, where they obtained a Bachelor of Science (BS) degree in Chemistry. Following this, they pursued higher education at the Massachusetts Institute of Technology from 1979 to 1983, and successfully earned a Doctor of Philosophy (Ph.D.) degree in Inorganic Chemistry.